EP
Eudaimonia Partners’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $657K | Sell |
3,609
-207
| -5% | -$37.7K | 0.16% | 137 |
|
|
2023
Q4 | $591K | Buy |
+3,816
| New | +$591K | 0.15% | 135 |
|
|
2023
Q3 | – | Sell |
-5,991
| Closed | -$807K | – | 329 |
|
|
2023
Q2 | $807K | Buy |
5,991
+410
| +7% | +$55.2K | 0.18% | 131 |
|
|
2023
Q1 | $889K | Sell |
5,581
-5,481
| -50% | -$874K | 0.21% | 110 |
|
|
2022
Q4 | $1.79M | Sell |
11,062
-3,050
| -22% | -$493K | 0.44% | 56 |
|
|
2022
Q3 | $1.89M | Sell |
14,112
-11,950
| -46% | -$1.6M | 0.49% | 50 |
|
|
2022
Q2 | $3.99M | Sell |
26,062
-37
| -0.1% | -$5.67K | 0.73% | 33 |
|
|
2022
Q1 | $4.23M | Buy |
+26,099
| New | +$4.23M | 0.72% | 27 |
|
|
2021
Q3 | $2.34M | Sell |
21,729
-1,469
| -6% | -$158K | 0.42% | 68 |
|
|
2021
Q2 | $2.61M | Buy |
23,198
+3,091
| +15% | +$348K | 0.49% | 52 |
|
|
2021
Q1 | $2.18M | Sell |
20,107
-1,882
| -9% | -$204K | 0.45% | 55 |
|
|
2020
Q4 | $2.36M | Sell |
21,989
-270
| -1% | -$28.9K | 0.53% | 50 |
|
|
2020
Q3 | $1.95M | Sell |
22,259
-2,072
| -9% | -$182K | 0.5% | 52 |
|
|
2020
Q2 | $2.39M | Buy |
24,331
+1,223
| +5% | +$120K | 0.91% | 26 |
|
|
2020
Q1 | $1.76M | Buy |
23,108
+4,918
| +27% | +$375K | 0.77% | 31 |
|
|
2019
Q4 | $1.61M | Buy |
+18,190
| New | +$1.61M | 0.64% | 40 |
|